Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

141
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
141
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

232
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
232
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

370
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
370
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

440
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
440
Beck's Cognitive Therapy01:25

Beck's Cognitive Therapy

135
Cognitive therapy is a psychological approach designed to address distortions in thinking, which can lead to negative emotions and unrealistic beliefs. These cognitive distortions often influence how individuals interpret and respond to situations, exacerbating emotional distress. Below are some prevalent cognitive distortions, their characteristics, and examples of how they manifest in thought processes.
Arbitrary Inference
Arbitrary inference involves making conclusions without sufficient...
135
Dementia01:30

Dementia

213
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
213

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of genomic science in males with breast cancer.

Nursing·2026
Same author

Beyond Checking a Box: Embracing and Navigating Ethical Authorship.

Clinical journal of oncology nursing·2026
Same author

Errors in Germline Biomarker Testing: Significant Consequences and Missed Opportunities for Cancer Control in Patients and Their Families.

Cancer journal (Sudbury, Mass.)·2026
Same author

Quality and Safety Imperatives in the Identification and Management of Hereditary Cancer Syndromes.

Seminars in oncology nursing·2026
Same author

Educating Nurses for Genomics-Informed Cancer Care: Strengthening the Current and Future Workforce.

Seminars in oncology nursing·2026
Same author

Seminal Editorial: Who We Are.

Clinical journal of oncology nursing·2025
Same journal

How Can Oncology Nurses Learn to See Beyond the Numbers?

Clinical journal of oncology nursing·2026
Same journal

Care of Patients Receiving Abemaciclib: Results From Clinical Trials and a Healthcare Provider Survey.

Clinical journal of oncology nursing·2026
Same journal

The Role of Oncology Nurses in National Breast and Cervical Cancer Screening Programs.

Clinical journal of oncology nursing·2026
Same journal

Technology-Assisted Nutrition Education Program for Patients With Cancer Undergoing Gastrectomy: A Quasi-Experimental Study.

Clinical journal of oncology nursing·2026
Same journal

The Hidden Biology of Life Experience: Using SEMOARS + GEM and Precision Health for Psychoneurologic Symptoms in Hematologic Malignancies.

Clinical journal of oncology nursing·2026
Same journal

GLP-1 Medications in Oncology Nursing Practice.

Clinical journal of oncology nursing·2026
See all related articles

Related Experiment Video

Updated: Oct 12, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

868

Cognitive Dysfunction: Common Side Effect.

Suzanne M Mahon1, Ellen Carr2

  • 1Saint Louis University.

Clinical Journal of Oncology Nursing
|November 20, 2021
PubMed
Summary
This summary is machine-generated.

Cognitive dysfunction, a decline in mental abilities, affects many patients with serious illnesses like brain tumors and cancer. Current care standards rely on evidence-based practices to manage these cognitive impairments.

Keywords:
cancerlong-term side effectsside effectssurvivorship caresymptoms

More Related Videos

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.6K
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
10:10

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy

Published on: October 18, 2011

12.8K

Related Experiment Videos

Last Updated: Oct 12, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

868
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.6K
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
10:10

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy

Published on: October 18, 2011

12.8K

Area of Science:

  • Neurology
  • Oncology
  • Psychology

Background:

  • Cognitive dysfunction is a significant issue impacting patients with various medical conditions.
  • It involves a decline in critical cognitive domains such as memory, attention, and executive function.
  • Prevalence rates are high, affecting 80% of brain tumor patients, 40% of acute myeloid leukemia patients, and up to 75% of breast cancer patients.

Purpose of the Study:

  • To define cognitive dysfunction and its scope.
  • To highlight the prevalence of cognitive dysfunction in specific patient populations.
  • To underscore the importance of evidence-based practices in managing cognitive decline.

Main Methods:

  • Review of established evidence-based practices for cognitive dysfunction.
  • Definition and categorization of cognitive domains affected by dysfunction.
  • Analysis of prevalence data in key oncological and hematological patient groups.

Main Results:

  • Cognitive dysfunction is characterized by impaired performance in multiple cognitive domains.
  • High incidence rates of cognitive dysfunction are observed across different cancer types and leukemia.
  • Standards of care are guided by evidence-based practice for managing cognitive impairments.

Conclusions:

  • Cognitive dysfunction is a common and serious complication in patients with brain tumors and certain cancers.
  • Evidence-based practices form the foundation for managing cognitive decline in these patient populations.
  • Further research may explore targeted interventions to mitigate cognitive dysfunction in affected individuals.